ADMA Biologics Inc vs Microchip Technology Inc. — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Microchip Technology Inc. trades at $82.15 (market cap $43.99B). The key difference: Microchip Technology Inc. is far larger — about 19.8× ADMA Biologics Inc's market cap, and Microchip Technology Inc. pays a 2.25% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | MCHP | |
|---|---|---|
Market Cap | $2.22B | $43.99B |
Sector | Health | Technology |
52-Week High | $20.38 | $102.97 |
52-Week Low | $7.60 | $49.02 |
Enterprise Value | $2.29B | $49.12B |
Dividend Yield | — | 2.25% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →